In Brief: Immunomedics' LeukoScan
This article was originally published in The Gray Sheet
Executive Summary
Immunomedics' LeukoScan: Infectious disease imaging agent for use in detecting and diagnosing osteomyelitis (bone infection) involving long bones is cleared for marketing in European Union countries. The approved indication applies particularly to patients with diabetic foot ulcers. A biologic license application is pending at FDA to support use of the radiolabeled monoclonal antibody fragment for the same indication as that approved in the EU, as well as for use in detecting acute atypical appendicitis...
You may also be interested in...
Palatin's LeuTech Clinically Useful For Appendicitis Diagnosis - FDA Panel
Clinical management decisions on whether to use computed tomography (CT) or Palatin's LeuTech imaging agent for detecting appendicitis in patients with equivocal appendicitis likely will depend on an institution's level of expertise with each modality.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.